4534 — Mochida Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥107bn
- ¥63bn
- ¥103bn
- 54
- 55
- 38
- 46
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 11,642 | 6,273 | 11,900 | 14,591 | 9,044 |
Depreciation | |||||
Non-Cash Items | -924 | 2,552 | 305 | 127 | -760 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,071 | -2,209 | -5,751 | -9,947 | -3,659 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 12,564 | 9,347 | 9,196 | 7,460 | 7,297 |
Capital Expenditures | -1,368 | -1,958 | -1,935 | -2,988 | -2,166 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 247 | 198 | 1,055 | 981 | -783 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,121 | -1,760 | -880 | -2,007 | -2,949 |
Financing Cash Flow Items | -46 | 0 | -1 | 0 | 0 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | -6,094 | -5,328 | -5,112 | -5,956 | -6,884 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 5,349 | 2,259 | 3,195 | -472 | -2,504 |